Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Restructurally sound

Facing dwindling product pipelines and looming patent cliffs, nearly all of the world's major drugmakers have recently overhauled their research and development activities. Brendan Borrell asks what difference these efforts have made.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borrell, B. Restructurally sound. Nat Med 17, 531–533 (2011). https://doi.org/10.1038/nm0511-531

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0511-531

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing